Prevalence of primary genotypic resistance in a UK centre: Comparison of primary HIV-1 and newly diagnosed treatment-naive individuals

AIDS

Volumn 21, Issue 2, 2007, Pages 237-239

  Fox, Julie ^a,b   Hill, Samantha ^a   Kaye, Steve ^b   Dustan, Simon ^b   McClure, Myra ^b   Fidler, Sarah ^a,b   Mackie, Nicola E ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC HETEROGENEITY; GENETIC RESISTANCE; GENETIC VARIABILITY; GENOTYPE; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; MUTATION; PRIORITY JOURNAL; STRUCTURAL GENE; UNITED KINGDOM; VIROLOGY;

ADULT; AGED; DRUG RESISTANCE, VIRAL; FEMALE; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED;

EID: 33845920015     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000247577.26375.ef     Document Type: Article

References (16)

1. Ammaranond P, Cunningham P, Oelrichs R, Suzuki K, Harris C, Leas L, et al. Rates of transmission of antiretroviral drug resistant strains of HIV. J Clin Virol 2003; 26:153-161.
2. Blower SM, Aschenbach AN, Kahn JO. Predicting the transmission of drug-resistant HIV: comparing theory with data. Lancet Infect Dis 2003; 3:10-11.
3. Leigh Brown AJ, Frost SD, Mathews WC, Dawson K, Hellmann NS, Daar ES, et al. Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population. J Infect Dis 2003; 187:683-686.
4. Little SJ, Holte S, Routy JP, Daar ES, Markowitz M, Collier AC, et al. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med 2002; 347:385-394.
5. Yerly S, Vora S, Rizzardi P, Chave J-P, Vernazza PL, Flepp M, et al. Acute HIV infection: impact on the spread of HIV and transmission of drug resistance. AIDS 2001; 15:2287-2292.
6. UK Collaborative Group on Monitoring the Transmission of HIV Drug Resistance. Analysis of prevalence of HIV-1 drug resistance in primary infections in the United Kingdom. BMJ 2001; 322:1087-1088.
7. UK Group on transmitted drug resistance. Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational centre. BMJ 2005; 331:1368-1373.
8. Briones C, Perez-Olmeda M, Rodriguez C, del Romero J, Hertogs K, Soriano V. Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid. J Acquir Immune Defic Syndr 2001; 26:145-150.
9. Boden D, Hurley A, Zhang L, Cao Y, Guo Y, Jones E, et al. HIV-1 drug resistance in newly infected individuals. JAMA 1999; 282:1135-1141.
10. Salomon H, Wainberg MA, Brenner B, Quan Y, Rouleau D, Cote P, et al. Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection Study. AIDS 2000; 14:F17-F23.
11. Little SJ. Is transmitted drug resistance in HIV on the rise? It seems so. BMJ 2001; 7294:1074-1075.
12. Gazzard B. British HIV Association (BHIVA) guidelines for the treatment of HIV infected adults with antiretroviral therapy (2005). HIV Med 2005; 6:1-61.
13. Fox JM, Fidler SJ, Weber J. Resistance to HIV drugs in the UK may be lower in some areas. BMJ 2006; 332:180-189.
14. Garcia A, Booth C, Nebbia G, Chawla A, Geretti AM, et al. The demographic, clinical and virological characteristics of patients newly diagnosed with non-B HIV-1 subtypes in London. HIV Med; 7:1 [April 2006. Oral Abstracts BHIVA 2006] 2006; [Oral abstract O2].
15. Johnson VA, Brun-Vézinet F, Clotet B, Conway B, Kuritzkes DR, Pillay D, et al. Update of the drug resistance mutations in HIV-1: fall 2005. Top HIV Med 2005; 13:125-131.
16. Fox J, Duda A, Dunstan S, McClure M, Weber JN, Phillips RE, Fidler S. Transmitted drug resistant HIV-1 in London; incidence, evolution and effect on disease progression. HIV Med 2006; in press.